27th Nov 2015 08:07
LONDON (Alliance News) - Rex Bionics PLC Friday said it had seen positive results from an interim analysis of and ongoing clinical trial of its REX technology for users with spinal cord injury.
Rex Bionics makes a robotic exoskeleton, called REX, which allows wheelchair users to stand and walk. The clinical trial is to evaluate the safety and feasibility of a set of customised exercises performed in a REX system.
The data shows that REX can be safely used by people with spinal cord injury, with 19 out of 20 volunteers able to complete the walk exercise protocol that was the primary endpoint of the trial.
"I am delighted by these positive results. They are a strong message to those philanthropists who are considering donating a REX to their local rehabilitation centre; and to insurance and tax-funded healthcare systems," said Chief Executive Crispin Simon in a statement.
Shares in Rex Bionics were untraded Friday morning. It last traded at 45.00 pence.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
RXB.L